The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
about
Wnt5a Signaling in CancerWNT-5A: signaling and functions in health and diseaseTherapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesisThe role of Ryk and Ror receptor tyrosine kinases in Wnt signal transductionFrizzled homolog proteins, microRNAs and Wnt signaling in cancerProtein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior.A PTK7/Ror2 Co-Receptor Complex Affects Xenopus Neural Crest MigrationLive imaging of Xwnt5A-ROR2 complexesWNT5A encodes two isoforms with distinct functions in cancersA switch from canonical to noncanonical Wnt signaling mediates drug resistance in colon cancer cellsBoth canonical and non-canonical Wnt signaling independently promote stem cell growth in mammospheresWnt5a inhibits the proliferation and melanogenesis of melanocytesMethylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasionRor2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerizationWnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.For robust big data analyses: a collection of 150 important pro-metastatic genesWNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progressionControl of hair follicle cell fate by underlying mesenchyme through a CSL-Wnt5a-FoxN1 regulatory axis.Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.Wnt5a is strongly expressed at the leading edge in non-melanoma skin cancer, forming active gradients, while canonical Wnt signalling is repressed.Wnt5a can both activate and repress Wnt/β-catenin signaling during mouse embryonic development.Expression of Ror2 mediates invasive phenotypes in renal cell carcinomaWnt5a as an effector of TGFβ in mammary development and cancerUp-regulation of ROR2 is associated with unfavorable prognosis and tumor progression in cervical cancerActivation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosisHigh ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy.Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis.Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression.Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell linesOver-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistanceHuman Cytomegalovirus Modulates Expression of Noncanonical Wnt Receptor ROR2 To Alter Trophoblast Migration.Regulation of lipid synthesis by the RNA helicase Mov10 controls Wnt5a production.Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.
P2860
Q26738408-6E100C4D-892E-44B2-9ACE-160B8DCEA747Q26777942-1B157063-63B7-4296-97F7-138CCDAFD1EAQ26782222-82490747-C969-4658-840C-9EDD41A447D1Q26829919-8022BC3E-2772-45E5-9F05-96147F12E304Q26852972-463113EA-02E7-47F8-B10E-7FB4943C4E88Q27010132-9BDB844F-2BC5-4602-B2AD-0D256EF80449Q27313355-5F0EB717-4F4F-4F83-A01D-DEDC4450B486Q27334633-4394486E-E2A9-475D-AE2C-41F8649A041DQ27339759-F40F6452-C99A-41A0-A8FD-838FE08E96EFQ28302422-E6E53AC5-A91E-4CBD-90DE-A17D53DBFE6CQ28477795-955291FC-235D-44BD-B25D-A0D15606592BQ28540692-89802D7D-68DA-4A9F-B09E-FFBF98F6AA4AQ28590609-AE1C2098-A54D-46B4-BA6B-69E4444E8853Q28741295-72F83238-6515-4A84-921F-FFA76728B0E4Q30495286-4BE34032-610C-4892-93C8-E47E0F277728Q30620714-5BF95F9F-7EE9-40C8-8F7D-A3F9686C042BQ31155755-372CC5AB-A0F6-4745-B729-B9EC26519CE1Q33634911-F117F8DC-D2FD-496F-8DA2-1BA4925371CDQ33808166-1171A4CF-609A-4C58-ABF7-DF7AA7520058Q33965278-BA992F43-90ED-444D-8BBF-49B890A8EFC3Q33998879-9200D5C9-4FEE-440F-B427-C285ABDE8DFAQ34041321-0EA6BBAA-8EB4-4E9E-9F14-1F945F58C558Q34181982-5E4BBC23-B737-4ACD-94EC-4DDBE19E9E4EQ34286592-6D2CD106-C571-4170-B4B6-5773D195207CQ34776854-8B243AF6-7FE9-4329-94DC-782F1D32E8DDQ35022625-13F71BC1-22F0-45DC-ACD0-A2702929DD55Q35145060-39C964F2-7BC4-4803-A837-1B0FB6A78522Q35182739-FB434F81-55BD-4984-9B88-00314419B450Q35492010-7B57CE96-14D9-4B1C-957B-98BCF271E789Q35872096-1FD4252D-3AD1-4567-B060-1069223F74A6Q35936126-D06702D7-29D6-456E-B7B6-F2E9BB1A3659Q35971763-20BBE0A5-0710-4FC0-8BEE-D9C22E084770Q36153315-E9A8E888-A1F5-407D-B667-48E379BB2C39Q36335326-4F4893E8-9ADE-49E8-AEA1-F6EBD190E3F1Q36381496-04A9194B-C958-4E4F-834F-9B1AEB1060DAQ36413067-36FF2F3F-913F-448F-B0C8-BB847979EF08Q36432043-9FFC4B46-8D38-4E1A-A9E8-8F6AD908E057Q36434181-333D99A3-BB29-4E7A-826F-C85A78342D59Q36579789-FE8E5B0F-69BB-4792-968A-32A299836CC9Q36596332-C57720F4-0AC8-4846-A488-0C577B632204
P2860
The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@ast
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@en
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@nl
type
label
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@ast
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@en
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@nl
prefLabel
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@ast
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@en
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
The orphan tyrosine kinase rec ...... gnaling in metastatic melanoma
@en
P2093
A D Carter
A D French
A T Weeraratna
S K Dissanayake
T C Camilli
P2860
P2888
P3181
P356
10.1038/ONC.2009.305
P407
P577
2009-10-05T00:00:00Z
P5875
P6179
1002911825